Browse By

Category Archives: News

Bitcoin’s price was expected to drop temporarily

After jumping around 15 percent and reaching it’s record high of $11,434, Bitcoin’s price has fallen more than 20 percent on the same day to recover a bit, later in the same day and traders witnessed a bumpy volatility in the crypto-market. However, experts stated

No Thumbnail

Whole Foods’ Lower Prices to Affect Everyone

Amazon says it is going to slash the price on a basket of items ranging from organic Fuji apples to “responsibly-farmed” tilapia but hasn’t specified by how much. Yet the idea that the upscale natural-foods-oriented chain with an outsized reputation for hefty price tags —

No Thumbnail

Teva Pharmaceutical Misses Q2 Profit Estimates

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported second quarter results that missed analysts’ estimates. In the second quarter, profit, excluding some costs, dropped to $1 billion from $1.23 billion a year earlier. That was lower than the $1.12 billion average of analysts’ estimates compiled by Bloomberg.

No Thumbnail

Apple’s Plea To Dismiss FaceTime Lawsuit Rejected

Apple’s bid to have a lawsuit which claimed that it deliberately caused FaceTime video conferencing tool not to function on older models of the iPhones so that the users could be forced to upgrade has been dismissed. Lucy Koh, a U.S. District Judge, gave a

No Thumbnail

3 analysts given BUY Applied Optoelectronics, Inc. (NASDAQ:AAOI)

Applied Optoelectronics, Inc. (NASDAQ:AAOI)’s stock on Thursday traded at beginning with a price of $95.47 and when day-trade ended the stock finally surged 4.80% to reach at $97.99. Analyst’s mean target price for AAOI is $80.00 while analysts mean recommendation is 2.00. Stock value has

No Thumbnail

7 analysts given BUY rating to eBay Inc. (NASDAQ:EBAY)

eBay Inc. (NASDAQ:EBAY)‘s stock on Thursday traded at beginning with a price of $35.97 and when day-trade ended the stock finally slumped -0.53% to reach at $35.71. Analyst’s mean target price for EBAY is $36.43 while analysts mean recommendation is 2.50. Stock value has moved

No Thumbnail

4 analysts given BUY rating to ImmunoGen, Inc. (NASDAQ:IMGN)

ImmunoGen, Inc. (NASDAQ:IMGN)’s stock on Thursday traded at beginning with a price of $5.49 and when day-trade ended the stock finally declined -1.64% to reach at $5.40. Analyst’s mean target price for IMGN is $7.67 while analysts mean recommendation is 2.10. Stock value has moved